GlassScriptPhysician profile
Melissa A Rubenstein
NPI 1164587671
$8,942.50
in general payments reported to CMS, 2019-2025
29 companies · $2,304 in 2025
The $2,304 reported for 2025 was more than what 79% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $423 · 2021: $805 · 2022: $1,238 · 2023: $1,506 · 2024: $2,271 · 2025: $2,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,080.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,173.70 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $1,052.59 | 2020-2025 | |
| Genzyme Corporation | $1,042.99 | 2019-2025 | |
| Galderma Laboratories, L.P. | $577.80 | 2019-2025 | Nemluvio, Aklief |
| Leo Pharma INC. | $539.73 | 2019-2025 | Adbry, Anzupgo |
| Amgen INC. | $393.84 | 2020-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $368.18 | 2020-2025 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $281.85 | 2019-2024 | Dupixent |
| Pfizer INC. | $242.91 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $207.27 | 2023-2024 | Sotyktu |
| Allergan, INC. | $166.82 | 2019-2022 | |
| Lilly USA, LLC | $152.20 | 2021-2025 | Ebglyss, Taltz |
| Arcutis Biotherapeutics, INC. | $135.97 | 2023-2025 | Zoryve |
| Incyte Corporation | $110.52 | 2021-2025 | Opzelura |
| Dermavant Sciences, INC. | $72.75 | 2022-2023 | Vtama |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $53.32 | 2019 | |
| Biofrontera INC. | $51.29 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $50.68 | 2020-2022 | |
| Prugen, INC. Pharmaceuticals | $49.59 | 2020 | |
| Organon LLC | $38.42 | 2025 | |
| Janssen Biotech, INC. | $34.51 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $24.44 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $22.61 | 2025 | Valchlor |
| Vyne Pharmaceuticals INC. | $19.48 | 2021 | |
| Krystal Biotech INC | $19.47 | 2023 | Vyjuvek |
| Encore Dermatology INC. | $19.26 | 2019 | |
| Genentech USA, INC. | $14.94 | 2023 | Xolair |
| Botanix Sb INC | $14.05 | 2025 | Sofdra |
| Sensus Healthcare, INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Rubenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.